Simplifying Access to Healthcare
Video Asset for Journalists
Download the PfizerForAll video asset for journalists.
Download Video AssetPfizer Launches PfizerForAll™, a Digital Platform that Helps Simplify Access to Healthcare
Pfizer Inc. today introduced PfizerForAll, a user-friendly digital platform designed to make access to healthcare and managing health and wellness more seamless for people across the U.S.
Read the Press ReleasePfizerForAll Strives to Simplify How You Access Healthcare
Our mission to make breakthroughs that change patients’ lives isn’t just about developing medicines and vaccines. We are also focused on improving the entire healthcare journey from start to finish.
Learn More About PfizerForAllPress Releases
All Pfizer published press releases by date and/or category of news
08.12.2022 Vaccines Vaccines Pfizer Announces Positive Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Infants 08.08.2022 Research and Pipeline Research Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15 08.08.2022 Financial Investments Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology
Trust in Technology – A Snapshot
Pfizer surveyed adults in 10 countries across the Global North and South to better understand the general population's trust in incorporating technology into the management of their healthcare. The results showed that 6 in 10 trust technology in this setting but that means 4 in 10 are at risk of being left behind. Our findings underscored that patients won’t feel the full benefits of that technology if we don’t have trusted people – specifically health care providers – delivering it. We must partner with patients, healthcare providers, policy makers and others in the life sciences and tech industries to build trust in the technologies that are fueling the future of health.
Downloadable InfographicDetails
![](https://cdn.pfizer.com/pfizercom/2024-01/Trust-in-technology-web.png?VersionId=2KG2ZtrRk3y.qirSYpPBLhhToMpIld5m)
Media Asset Library
A collection of assets for use by media.
Partnering News
The latest news from Pfizer and its strategic partners
06.29.2017 Partnerships Alcyone Lifesciences Enters into a Feasibility Study Agreement with Pfizer to Evaluate Alcyone’s proprietary PulsarTM Advanced Intrathecal Precision Delivery Platform Technology for use in Gene Therapy Targeting Central Nervous System Disorders 06.07.2017 Partnerships Sangamo Therapeutics And Pfizer Announce That Sb-525 Investigational Hemophilia A Gene Therapy Receives Orphan Medicinal Product Designation From The European Medicines Agency
Media Contacts
Pfizer Media Relations
We encourage everyone to view our press releases, press statements, and press kits to stay up to date on Pfizer news.
However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.
Media Contacts
General email
[email protected]
United States, Canada and Latin America
+1 212.733.1226
Europe, the Middle East and Africa
+44-(0)173.733.2335
[email protected]
Asia Pacific
+65.918.732.47
What we need
To best help us help you, please be prepared to provide your name and email address, a summary of the article you're working on and your deadline.
Other Frequently Visited Links
For more, see these helpful and often used sections of Pfizer.com
Pfizer Wire
Stay up to date on the latest news and alerts through the Pfizer Wire
Sign up to receive real-time updates on Pfizer’s news from the Pfizer Media Relations team delivered directly to your inbox.
Sign Up NowDetails
![](https://cdn.pfizer.com/pfizercom/2022-10/Pfizer_Brand-Motif_11%201%20%282%29.png?VersionId=JnyLe.ug92gda5lKzC5ji4yB3hAoYuia)